Brainstorm Cell Therapeutics, Inc. (BCLI)
1.08
+0.05
(+4.85%)
USD |
OTCM |
Sep 11, 16:00
Brainstorm Cell Therapeutics Market Cap : 11.92M for Sept. 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 11, 2026 | 11.92M |
| September 10, 2026 | 11.37M |
| September 09, 2026 | 11.03M |
| September 08, 2026 | 10.92M |
| September 04, 2026 | 11.59M |
| September 03, 2026 | 11.81M |
| September 02, 2026 | 13.79M |
| September 01, 2026 | 12.88M |
| August 31, 2026 | 11.75M |
| August 28, 2026 | 12.40M |
| August 27, 2026 | 12.83M |
| August 26, 2026 | 13.24M |
| August 25, 2026 | 11.03M |
| August 24, 2026 | 11.03M |
| August 21, 2026 | 10.81M |
| August 20, 2026 | 11.70M |
| August 19, 2026 | 13.43M |
| August 18, 2026 | 15.56M |
| August 17, 2026 | 11.98M |
| August 14, 2026 | 10.92M |
| August 13, 2026 | 9.004M |
| August 12, 2026 | 9.573M |
| August 11, 2026 | 9.380M |
| August 10, 2026 | 8.718M |
| August 07, 2026 | 8.690M |
| Date | Value |
|---|---|
| August 06, 2026 | 8.828M |
| August 05, 2026 | 8.562M |
| August 04, 2026 | 8.524M |
| August 03, 2026 | 8.718M |
| July 31, 2026 | 9.931M |
| July 30, 2026 | 10.13M |
| July 29, 2026 | 9.883M |
| July 28, 2026 | 10.15M |
| July 27, 2026 | 10.31M |
| July 24, 2026 | 10.59M |
| July 23, 2026 | 11.03M |
| July 22, 2026 | 10.81M |
| July 21, 2026 | 10.15M |
| July 20, 2026 | 10.48M |
| July 17, 2026 | 9.889M |
| July 16, 2026 | 10.40M |
| July 15, 2026 | 10.73M |
| July 14, 2026 | 10.59M |
| July 13, 2026 | 11.54M |
| July 10, 2026 | 11.92M |
| July 09, 2026 | 11.81M |
| July 08, 2026 | 12.58M |
| July 07, 2026 | 13.61M |
| July 06, 2026 | 14.35M |
| July 02, 2026 | 15.89M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| NovelStem International Corp. | 0.4687M |
| Summit Therapeutics, Inc. | 13.92B |
| Kezar Life Sciences, Inc. | 53.76M |
| Protara Therapeutics, Inc. | 225.70M |
| Clene, Inc. | 45.62M |
Market Cap Related Metrics
| Price | 1.08 |
| Earnings Yield | -88.34% |